Starling Oncology, Inc. (STLN) stock
STLNNasdaqServices-Offices & Clinics of Doctors of MedicineFiscal year ends December 31Also trades as DFPH, STLNW
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 7/30
$3.40−0.14 (-3.95%)
Close on Nov 17, 2026Market cap $346.52MP/E –Yield –
Starling Oncology enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Starling Oncology's enterprise value was $460.74M on Nov 11, 2026, against $354.91M a year earlier. Over the last 5 years it ranged from $44.18M to $694.84M, with a median of $212.72M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $460.74M | +16.4% |
| 2025 | Dec 31, 2025 | $395.89M | +486.6% |
| 2024 | Dec 31, 2024 | $67.48M | -54.5% |
| 2023 | Dec 29, 2023 | $148.25M | +37.5% |
| 2022 | Dec 30, 2022 | $107.85M | -49.3% |
| 2021 | Dec 31, 2021 | $212.72M | +248.1% |
| 2020 | Dec 31, 2020 | $61.10M | – |
See a number that looks wrong?